Feed/Companies/Tubulis

Tubulis

As of 14 Oct 2026, Tubulis has raised $358.0M across 1 verified round on record (amounts in other currencies converted to USD); latest: €308 million (USD 361 million) Series C led by Venrock Healthcare Capital Partners, announced 15 Oct 2025.

BUILT ON

Visit site

Tubulis develops antibody-drug conjugates for treating various cancers.

tubulis.comLinkedInBiotech

LATEST ROUND

Series C

$358.0M · 2025-10-15

RAISED ON RECORD · USD

$358.0M

across 1 verified round

INVESTORS

1 lead

SOURCES

from 1 publisher

Rounds

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series C

$358.0M · 2025-10-15

[ HISTORY ]

led by Venrock Healthcare Capital Partners

Round	Amount	Announced	Lead	Buzz
Series C [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$358.0M €308 million (USD 361 million)	2025-10-15	Venrock Healthcare Capital Partners	No recent discussion
1 source [ VERIFIED ] read against 1 source

Tubulis

Rounds

Company

Rounds

Sources

Profile

Investors

Tubulis

Rounds

Profile

Sources

Series C$358.0M2025-10-151 source

Investors

Series C$358.0M2025-10-1513 investors